Lasa Supergenerics Q1 FY27 Results: Net Loss of ₹3.6 Cr, Loss Narrows
Lasa Supergenerics Ltd reported revenue from operations of ₹1.2 Cr (-94.0% YoY) and a net loss of ₹3.6 Cr for Q1 FY27.
- Key figure
- Net loss ₹3.6 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
Lasa Supergenerics Ltd reported revenue from operations of ₹1.2 Cr (-94.0% YoY) and a net loss of ₹3.6 Cr for Q1 FY27.
Lasa Supergenerics reported its audited FY2026 financial results following a significant fire incident. The results carry a modified audit opinion due to asset impairment uncertainties.
Lasa Supergenerics Ltd reported revenue from operations of -₹0.1 Cr and a net loss of ₹4.2 Cr for Q4 FY26.
Lasa Supergenerics reported annual total income of ₹25.34 Crore for FY 2026. The company posted a net loss of ₹34.09 Crore following a significant fire incident.
Lasa Supergenerics Ltd reported a net loss of ₹2.6 Cr for Q3 FY26.